Aspirin modulates generation of procoagulant phospholipids in cardiovascular disease, by regulating LPCAT3Majd Protty, Valerie B. O’Donnell, David C. Bosanquet et al.|Journal of Lipid Research|2024Cited by 7
Common anti-platelet therapies modulate procoagulant phospholipids in arterial diseaseMajd Protty, Valerie B. O’Donnell, Victoria J. Tyrrell et al.|medRxiv|2022Cited by 1
TCT-240 The Device Success Algorithm of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Prospectively Applied to Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in the International Multivessel TALENT Randomized TrialPruthvi C. Revaiah, Patrick Serruys, Asahi Oshima et al.|Journal of the American College of Cardiology|2024Cited by 0
TCT-937 Short-term and Long-term forecasting of clinical events in the Multivessel TALENT Trial with de novo three vessel coronary artery disease populationYoshinobu Onuma, Akihiro Tobe, Pruthvi C. Revaiah et al.|Journal of the American College of Cardiology|2025Cited by 0